Jun 17, 2015 by Brian Feroldi5 Healthcare Stocks for Dividend LoversHere are five dividend-paying stocks you should considering adding to your watchlist.
Jun 14, 2015 by Brian FeroldiGilead Sciences' Next Growth MarketGilead recently received approval for Sovaldi in Japan. How big of an opportunity is this for the company?
Jun 11, 2015 by Brian Feroldi3 Things AbbVie Inc.'s Management Wants You to KnowAbbVie's management team had a lot to talk about on their last investor conference call. Here are my three takeaways you need to know when considering the stock for investment.
Jun 1, 2015 by Brian FeroldiWhy Shares of Oncothyreon Inc. Shot Up TodayOncothyreon stock was up big today. Is the movement meaningful, or just market noise?
Jun 1, 2015 by Brian FeroldiWhy CTI Biopharma Corp Is Soaring TodayShares of CTI Biopharma are up big today. Is the news meaningful, or just market noise?
Jun 1, 2015 by Brian FeroldiWhy I'm Buying Gilead Sciences StockA look at where Gilead stands today, its pipeline, and why it could be a great investment from here.
May 30, 2015 by Brian Feroldi, Todd Campbell, and Cheryl SwansonInvesting for Beginners: How to Start in BiotechBiotech can be tricky to learn, so we asked the experts to give their best advice to beginners. Here is what they said.
May 29, 2015 by Brian FeroldiIs MannKind a Buy?After exploring MannKind's past, present, and future, it's time to ask: Is MannKind a buy now?
May 27, 2015 by Brian FeroldiHow Will Big Pharma Fight Back Against MannKind?Afrezza, an inhaled insulin, is officially on the market, and threatens many big industry leaders. How will big pharma fight back against the inhaled insulin threat?
May 23, 2015 by Brian FeroldiCould Incoming Threats Sink MannKind Corporation?Big Pharma suspected that MannKind's Afrezza would make its way to the market eventually. Now that its here, what does the industry have in its pipeline that could potentially slow adoption?
May 21, 2015 by Brian FeroldiWhy Shares Of Dicerna Pharmaceuticals Are Down TodayShares of Dicerna Pharmaceuticals fell 10% today. Is the move meaningful, or just market noise?
May 19, 2015 by Brian FeroldiForget MannKind Stock's Price: Here's What You Need to Focus on InsteadIs MannKind's small share price tempting you to buy? Use this simple mental test to evaluate your decision.
May 17, 2015 by Brian Feroldi4 Reasons Why MannKind Could Succeed Where Pfizer Failed9 years ago Pfizer tried to launch an inhaled insulin called Exubera to the market and it failed. Here are 4 reasons why Afrezza could succeed where Pfizer came up short.
May 15, 2015 by Brian FeroldiWhy MannKind Stock Got New Life Breathed Into It TodayShares of MannKind Corp rocketed 12% higher today. Is the move meaningful, or just market noise?
May 14, 2015 by Brian FeroldiWhy Shares of Sangamo Biosciences Fell TodayShares of Sangamo Biosciences fell hard today after providing a clinical update at the American Society of Gene and Cell Therapy. Is the move meaningful, or just market noise?
May 13, 2015 by Brian FeroldiWhy ResMed's Stock Is in the Red TodayShares of ResMed fell today. Is the move meaningful, or just market noise?
May 7, 2015 by Brian FeroldiThe Best Company for Investing in the Diabetes MarketDiabetes spending is growing rapidly, and this company is the best way for investors to capitalize on the trend.
Apr 29, 2015 by Brian FeroldiMannKind's Future: More than Just Afrezza?MannKind's pipeline of opportunity is explored.
Apr 27, 2015 by Brian FeroldiMannKind Corporation: Past, Present, and FutureLet's learn about the history and future prospects of MannKind as it launches its first drug, Afrezza.
Apr 23, 2015 by Brian FeroldiIs Amgen Inc.'s Dividend Sustainable?Looking for income growth stocks? You need to look beyond the numbers.
